AI-Driven Blood Test Revolutionizes Lung Cancer Screening for High-Risk Non-Smokers in Asia
來源： PR Newswire Asia
Gene Solutions has launched SPOT-MAS Lung, an AI-powered blood test designed for early lung cancer detection, particularly targeting high-risk non-smokers in Asia. This innovative test aims to address the significant gap in current screening guidelines, which often overlook non-smokers and those with unclear imaging results. By integrating AI and multi-omics analysis, SPOT-MAS Lung offers a cost-effective and sensitive detection method, enhancing early diagnosis and treatment outcomes.
重點整理
SPOT-MAS Lung is a new blood test developed by Gene Solutions, utilizing AI and multi-omics analysis for early lung cancer detection.
The test is particularly beneficial for high-risk non-smokers in Asia, who are often missed by traditional screening methods.
It has a high sensitivity (90%) and specificity (92%), and significantly reduces the cost of detection.
SPOT-MAS Lung complements existing screening pathways and helps avoid missing high-risk individuals.
Gene Solutions is collaborating with community organizations to increase public awareness and accessibility of early lung cancer screening.
找不到符合尺寸 300 x 250 的素材
找不到符合尺寸 300 x 250 的素材
找不到符合尺寸 300 x 250 的素材